²é¿´: 942  |  »Ø¸´: 5

wuweibewin

½ð³æ (ÕýʽдÊÖ)

[½»Á÷] һƪת»ùÒò×÷ÎﰲȫÐÔÎÄÕµļòµ¥·­Òë---¿ÆÑ§ÊµÀý

ËùÓÐÓõ½µÄʵÑéÖ¤¾Ý¾ùÀ´×Ô´ËÎÄÕÂÖеıí¸ñ¡ª¡ª
¡¶A literature review on the safety assessment of genetically modified plants¡·
Jos¨¦ L. Domingo ⁎, Jordi Gin¨¦ Bordonaba
Laboratory of Toxicology and Environmental Health, School of Medicine, IISPV, Universitat Rovira i Virgili, Sant Llorenç 21, 43201 Reus, Catalonia, Spain
ΪÁË·½±ã¸÷λ͵ÀÁµÄ¶øÇÒÓиÐÐËȤͬѧ²é¿´£¬ÎÒ¼òµ¥µÄ°ÑËûÃÇ·­Òë³ÉÖÐÎÄ£¬±¾ÈËÓ¢Óïˮƽһ°ã·­ÒëÄÑÃâ´íÎó¾´ÇëÔ­Á¡£
Ê×ÏÈÉùÃ÷±¾ÈËÊÇ×öת»ùÒòµÄ£¬¶Ôת»ùÒòÎÞÆçÊÓ£¬Ò²ÎÞÊ²Ã´ÌØ±ðµÄ¹Ûµã£¬¼È²»¹Ä´µ£¬Ò²²»±áÒÖ£¬ËùÓз­ÒëÎÊÌ⣬¿ÉÒÔÌÖÂÛ½á¹ûÕæÊµÐÔ¾´Çë²éѯԭʼÎÄÏ××Ô¼º·ÖÎö£¬±¾ÈËÄÑÒԻشðÄÇЩʵÑéÉè¼ÆµÄÎÊÌ⣬ÒòΪ¸ÃÎÄÏ×ËùÉæ¼°µÄԭʼÎÄÏ×ÎÒҲû¿´£¬ÎÞ·¨¸øÓè´ó¼ÒÍêÈ«µÄ½â´ð£»ÁíÍâËùÓÐ×¢ÃûµÄ¹«Ë¾Ãû³Æ³öÏÖ´íÎóÒ²ÇëÔ­Á£¬ÎÄÕÂÖв¢Î´Áгö¹«Ë¾Ãû³Æ£¬´ó²¿·Ö¹«Ë¾Ãû²îͨ¹ý°Ù¶È²é³ö£¬´íÎóÔÚËùÄÑÃ⣻»ùÒòÃû³Æ×¢Ã÷ÀýÈç²Ý¸Ê좿¹ÐÔ»ùÒòºÍÂȻǡ¿¹ÐÔ»ùÒòÕâÖÖ×¢½âÔÚרҵ½Ç¶ÈÉÏÀ´ËµÊDz»Ç¡µ±µÄ£¬µ«ÎªÁËÊ¡ÊÂÎÒʹÓôËÖÖ×¢Ã÷·½·¨£»Ö²ÖêÖÐÓ¦¸Ã»¹ÓÐɸѡ±ê¼Ç»ùÒòµÄ´æÔÚ£¬µ«Î´ÉîÈëÈ¥²éÃ÷£¬Ò²¾´ÇëÔ­Á£»²»Í¬ÊµÑéËùÓõÄСÊóµÄÀàÐͲ¢²»Ïàͬ£¬Ð¡ÊóÖÖÀàÔ­ÎÄÕÂÖпÉÒÔÕÒµ½ÎÒÕâÀïΪÁËÊ¡ÊÂҲʡȥÁË£»ËùÒÔ±¾ÎÄÖ»¹©·ÇרҵÈËÊ¿½»Á÷ÌÖÂÛʹÓã¬×¨ÒµÒýÓÃÇëȥԭʼÎÄÏ×ÖÐѰÕÒ£»ÕýÒòΪ´ËÎÄÖгöÏÖÈç´Ë¶àµÄÎÊÌ⣬ËùÒÔÖ»ÔÚÐÝÏйàË®Öз¢±í¡£¸ÐÐËȤµÄ¿ÉÒÔ¿´¿´£¬ÅÄשµÄÒ²ÇëÊÖÏÂÁôÇé¡£ÎÄÕÂËù²ÉÓõÄÀý×ÓÖ÷ÒªÊÇ2006-2009µÄ¿Æ¼¼ÎÄÏס£
²ÉÓÃ˳Ðò£º²Î¿¼ÎÄÏ×---Æ·ÖÖºÅ--ÍâÔ´»ùÒòÃû³Æ---ʵÑé·½·¨---¸ºÃæÓ°Ïì---ÆäËû

Ò»¡¢ÓñÃ×µÄÑо¿
1¡¢S¨¦ralini et al. (2007) ---ÃÏɽ¶¼¹«Ë¾MON 863---(Bt) Cry3Bb1µ°°×±àÂë»ùÒò£¨¿¹ÓñÃ׸ùÒ¶¼×£©----СÊóËÇιʵÑ飨90Ì죩
Ö÷ÒªµÄ¸ºÃæÓ°Ï죺Slight but dose-related weight variations in both males (3.3% reduction) and females (3.7% increase). Signs of hepatorenal toxicity, increased triglycerides in females (24¨C40%) and urine phosphorus and sodium excretions diminished in males (31¨C35%)
¼òµ¥¸ÅÀ¨Îª£º´ÆÐÔºÍÐÛÐÔСÊóÌåÖØ¶¼Êܵ½Ó°Ïì¡¢¸ÎÉö³öÏÖ¶¾ÐÔÐźš¢´ÆÐÔÖиÊÓÍÈýõ¥º¬Á¿Ôö¼Ó¡¢ÐÛÐÔÖÐÄòÖÐÁ׺ÍÄÆÏ½µ¡£
ÆäËû£ºÓÉÃÏɽ¶¼¹«Ë¾½éµ¼µÄרÃŵĵ÷²é×éºÍS¨¦ralini¶Ô¸Ã½á¹û½øÐе÷²é£¬µÃ³ö½áÂÛÊÇûÓÐʵ¼ÊÖ¤¾Ý¿ÉÒÔÖ¤Ã÷СÊóµÄÖ¢×´ÓëMON 863Óйء£-----The Expert Panel concluded that the reanalysis conducted by S¨¦ralini et al. (2007) provided no evidence to indicate that MON 863 was associated with adverse effects in the 90-day rat study¡£In each case, statistical findings reported by bothMonsanto and S¨¦ralini et al. (2007)were considered to be unrelated to treatment or of no biological or clinical importance because they failed to demonstrate a dose¨Cresponse relationship, reproducibility over time, association with other relevant changes (e.g., histopathology), occurrence in both sexes, difference outside the normal range of variation, or biological plausibility with respect to cause-and-effect.£¨ÃÏɽ¶¼Óë¸Ã¿ÎÌâ×éµÄ½á¹ûÈÔ´æÔÚÕùÒ飩

2¡¢Doull et al. (2007)--ÃÏɽ¶¼¹«Ë¾MON 863---(Bt) Cry3Bb1µ°°×±àÂë»ùÒò£¨¿¹ÓñÃ׸ùÒ¶¼×£©----СÊóËÇιʵÑ飨90Ì죩
½áÂÛ£ºÎ´·¢ÏÖ¸ºÃæÓ°Ïì¡£--No evidence of adverse effects¡£

3¡¢de Vendômois et al. (2009)--ÃÏɽ¶¼NK603(°üº¬³ý²Ý¼Á²Ý¸Ê좿¹ÐÔ»ùÒò)¡¢MON 810£¨Cry1Abµ°°×±àÂë»ùÒò£©¡¢ MON 863£¨Cry3Bb1µ°°×±àÂë»ùÒò£©---СÊóËÇιʵÑ飨14ÖÜ£©
½áÂÛ£º¶ÔʳÓÃÈýÖÖת»ùÒòÓñÃ×µÄСÊóÑо¿·¢ÏÖ´æÔÚÐÔ±ðºÍ¼ÁÁ¿ÒÀÀµµÄ¸±×÷Óã¬Ö÷ÒªÓë¸ÎÉö¶¾ÐÔÓйأ¬Ò²ÔÚÐÄÔࡢƢÔà¡¢ÉöÉÏÏÙ¡¢ÔìѪϵͳÖз¢ÏÖ´æÔÚ¸ºÃæÓ°Ïì¡£Sex- and dose-dependent side effects linked with consumption of 3 GMOs and mostly associated with hepatorenal toxicity. Other adverse effects were also detected in heart, spleen, adrenal glands and hemopoietic system¡£

4¡¢MacKenzie et al. (2007)--ÃÀ¿Æ¸ù-ÈûµÂ˹¹«Ë¾£¨¶Å°îÏÈ·æ+ÌÕÊÏ£©1507---±í´ïcry1F»ùÒòÑ¡ºÍÔñÐÔ±ê¼ÇµÄ¿¹³ý²Ý¼Á»ùÒòpat--СÊóËÇιʵÑ飨90Ì죩
½áÂÛ£ºÒ»¾ä»°--δ·¢ÏÖ¸ºÃæÓ°ÏìNo significant differences were observed in nutritional performance variables, clinical and neurobehavioral signs, ophthalmology and clinical pathology, organ weights and gross and microscopic pathology between treatment groups

5¡¢Malley et al. (2007)--£¨¶Å°î£©Ïȷ湫˾ת»ùÒòÓñÃ×59122--cry34Ab1 Óëcry35Ab1(delta-endotoxin)»ùÒòºÍ¿¹³ý²Ý¼Á»ùÒòp a t (Á×ËáÒÒõ£×ªÒÆÃ¸)»ùÒò--СÊóËÇιʵÑ飨90Ì죩
½áÂÛ£ºÎ´·¢ÏÖ¸ºÃæÓ°Ï죻No adverse diet-related differences in body weight, food consumption, clinical signs of toxicity, mortality, ophthalmology, neurobehavioral assessments, clinical pathology and pathology

6¡¢Appenzeller et al. (2009a)--Maize 1507¡Á59122£¨ÔÓ½»£©--СÊóËÇιʵÑ飨92Ì죩
½áÂÛ£ºÎ´·¢ÏÖ¸ºÃæÓ°ÏìNo significant differences were observed in nutritional performance variables, clinical and neurobehavioral signs, ophtalmology and clinical pathology, organ weights and gross and microscopic pathology between treatment groups

7¡¢Appenzeller et al. (2009b)--Ïȷ湫˾DP-9814-6--expresses the GAT4621(glyphosate acetyltransferase)»ùÒò ºÍ ZM-HRA(modified version of a maize acetolactate synthase£©»ùÒò --СÊóËÇιʵÑ飨13ÖÜ£©
½áÂÛ£ºÎ´·¢ÏÖ¸ºÃæÓ°Ï죺No adverse effects were observed in nutritional performance variables

8¡¢Juberg et al. (2009)--Maize 59122b--СÊóËÇιʵÑ飨28Ì죩
½áÂÛ£ºÎ´·¢ÏÖ¸ºÃæÓ°Ï죺No signs of acute toxicity or adverse effects due to diets containing high concentrations of Cry34Ab1 or Cry35Ab1 proteins, individually or concomitantly, were found at concentrations nearly 1000-fold greater than those found in 59122 maize grains and OECD 408-compliant toxicological response variables

9¡¢McNaughton et al. (2007)--Maize DP-9814-6--È⼦ËÇιʵÑ飨42Ì죩
½áÂÛ£ºÎ´·¢ÏÖ¸ºÃæÓ°Ï죻No significant differences in mortality, growth performance variables or carcass and organ yields. Adverse-toxic effects of the transgenic maize were not assessed.

10¡¢He et al. (2008)--Ïȷ湫˾DAS-59122-7--Cry34Ab1 »ùÒòºÍ Cry35Ab1 »ùÒò--СÊóËÇιʵÑ飨90Ì죩
½áÂÛ£º·¢ÏÖijЩѪҺºÍѪÇå·´Ó¦µÄ²»Í¬£¬È´±»¹éÒòÓÚËÇιת»ùÒòÓñÃ×µÄСÊóµÄʳÎïÖаüº¬¹ý¶àµÄÓñÃ×Ãæ£¬×îÖÕÊÇδ·¢ÏÖ¸ºÃæÓ°ÏìSignificant differences in certain hematology and serum chemistry response variables, but attributed to diets containing high maize flour (compared to control diets). It was concluded that 59122 maize grains were as safe as non-transgenic maize diets¡£

11¡¢He et al. (2009)-- £¨¹ú²ú-Å©´ó£©Y642 (lysine-rich)¡ªÀÁµÄÈ¥ÕÒÄ¿µÄ»ùÒòÁË-¡ªÐ¡ÊóËÇιʵÑ飨90Ì죩
½áÂÛ£ºÖйúÈ˲éÖйúÈ˽á¹û×ÔÈ»²»ÓÃ˵£ºÎ´·¢ÏÖ¸ºÃæÓ°ÏìNo adverse diet-related adverse effects in body weight, feed consumption, clinical chemistry, hematology, and absolute and relative organ weightsδ·¢ÏÖ¸ºÃæÓ°Ïì¾Í°ÕÁË£¬È˼ÒÀµ°±ËáÌá¸ßÁË£¬ÄãÁ¬¸öÕýÃæÓ°Ï춼ûÓУ¬Õâ²»Äܲ»ËµÓÐÎÊÌâ¡£

12¡¢Healy et al. (2008)¡ªÃÏɽ¶¼¹«Ë¾MON 88017--Cry3Bb1µ°°×»ùÒò+²Ý¸Ê좿¹ÐÔ»ùÒò--СÊóËÇιʵÑ飨13ÖÜ£©
½áÂÛ£ºÎ´·¢ÏÖ¸ºÃæÓ°Ïì No adverse health effects were noticed.

13¡¢Herouet-Guicheney et al. (2009)--- Maize (2mEPSPS)¡ª²Ý¸Ê좿¹ÐÔ»ùÒò¡ªÐ¡ÊóËÇιʵÑé
½áÂÛ£ºÎ´·¢ÏÖ¸ºÃæÓ°ÏìThe safety evaluation concluded that the protein was innocuous and hence could be included in human food or animal feed.

14¡¢Tutel'ian et al. (2008,2009) --ÏÈÕý´ïMIR604£¨cry3A£©+ÃÏɽ¶¼MON 88107£¨Cry3Bb1µ°°×»ùÒò+²Ý¸Ê좿¹ÐÔ»ùÒò£©
½áÂÛ£ºÎ´·¢ÏÖ¸ºÃæÓ°ÏìAnalysis of morphological, hematological and biochemical parameters
and system sensitive biomarker did not reveal any toxic effect.

15¡¢Tutel'ian et al. (2008,2009) --ÏÈÕý´ïMIR604£¨cry3A£©+ÃÏɽ¶¼MON 88107£¨Cry3Bb1µ°°×»ùÒò+²Ý¸Ê좿¹ÐÔ»ùÒò£©
½áÂÛ£ºÎ´·¢ÏÖ¸ºÃæÓ°ÏìAnalysis of DNA damage and structural chromosome aberrations, assessment of allergenic potential and immunoreactive properties did not show any genotoxic, allergenic and immunoreactive effects.

¶þ¡¢Ë®µ¾µÄÑо¿£º
1¡¢Schrøder et al. (2007)¡ªÕã½­´óѧKMD1-- cryAb»ùÒò----СÊóËÇιʵÑ飨90Ì죩
½áÂÛ£ºÎ´·¢ÏÖ¸ºÃæÓ°Ï죬ËäÈ»ÔÚÐÐΪºÍÌåÖØÉϲ¢Î´·¢ÏÖ²»Í¬£¬µ«ÔÚѪҺ²ÎÊýºÍÉú»¯²ÎÊýÉÏÓÐÉÙÐí²»Í¬£¬µ«ÈÔÔÚÕý³£·¶Î§Ö®ÄÚ¡£ÔÚÆ÷¹ÙÖØÁ¿¡¢ºê¹ÛºÍ×éÖ¯²¡Àíѧ¼ì²éÖÐÒ²·¢ÏÖ½ÏСµÄ²î±ð¡£No adverse effects on animal behavior or weight gain. Few hematological and biochemical parameters were significantly different between treatment diets. However, all were within the normal reference intervals for rats of this breed and age. Minor changes were observed in organs weight and macroscopic and histopathological examinations.

2¡¢Poulsen et al. (2007a,b)-- Rice expressing GNA lectin¡ª±í´ïÑ©»¨Á«Ö²ÎïÄý¼¯ËØ»ùÒò--СÊóËÇιʵÑ飨90Ì죩
½áÂÛ£ºÎ´·¢ÏÖ¸ºÃæÓ°Ï죬µ«ÊÇÐí¶àÁÙ´²µÄ¡¢ÉúÎïѧµÄ¡¢ÃâÒßѧµÄ¡¢Î¢ÉúÎïѧµÄ¡¢²¡Àíѧ²ÎÊýµÄÏÔÖø²»Í¬£¨Óë¶ÔÕÕСÊóÏà±È£©£¬×÷ÕßÉùÃ÷¸ÃÑо¿²¢²»ÄÜ×÷Ϊ²úÆ·°²È«ÐԵĵÄÒÀ¾Ý¡£No adverse effects were observed. However, a range of clinical, biological, I mmunological, microbiological and pathological parameters were significantly different between diet groups. The authors remarked that the design of their study was not able to conclude on the safety of the product.

3¡¢Kroghsbo et al. (2008)-- Rice expressing Cry1Ab protein £¨Cry1Ab»ùÒò£©or PHA-E lectin£¨²Ë¶¹Äý¼¯ËØE»ùÒò£©--СÊóËÇιʵÑ飨28ÌìºÍ90Ì죩
½áÂÛ£ºËÇι±í´ïPHA-E lectinµÄת»ùÒòË®µ¾»òÕßÖ±½ÓËÇιº¬0.1%µÄ´¿»¯µÄPHA-EÄý¼¯ËØ90Ì죬³öÏÖ¼ÁÁ¿ÒÀÀµÐÔ³¦ÏµÄ¤ÁܰͽáÖØÁ¿ºÍ×ÜÃâÒßÇòµ°°×AÔö¼Ó¡£¶øÔÚ±í´ïCry1Ab»ùÒòµÄË®µ¾ÔòûÓгöÏÖÈκÎÒì³£¡£A dose-dependent increase in mesenteric lymph node weight and total immunoglobulin A was seen when feeding PHA-E transgenic rice alone or spiked with 0.1% purified PHA-E lectin for 90 days. No adverse effects of Cry1Ab protein were found.

4¡¢Domon et al. (2009)-- Rice containing 7Crp¡ª×ªÓÐÆß¸ö±àÂëÈËÀàTϸ°û±íÃæ¿¹Ô­µÄ»ùÒò¡ªâ¨ºïËÇι26ÖÜ
½áÂÛ£ºÎ´·¢ÏÖ¸ºÃæÓ°ÏìNo adverse effects on general behavior or body weight, hematological and biochemical variables. No pathological symptoms or histopathological abnormalities.

´ó¶¹
1¡¢Appenzeller et al. (2008)¡ªÏȷ湫˾´ó¶¹DP-356Ø43-5¡ª×ªÈëÁ˲ݸÊ좿¹ÐÔ»ùÒòºÍÂȻǡ¿¹ÐÔ»ùÒò--СÊóËÇιʵÑ飨>93Ì죩
½áÂÛ£ºÎ´·¢ÏÖ¸ºÃæÓ°ÏìNo adverse effects on body weight/gain, food consumption, clinical signs, mortality, ophthalmology, neurobehavioral assessment, clinical pathology, organ weights and gross and microscopic pathology

2¡¢McNaughton et al. (2008)¡ªÏȷ湫˾ת»ùÒò´ó¶¹ DP-356Ø43-5¡ªËÇι¼¦42Ìì
½áÂÛ£ºÎ´·¢ÏÖ¸ºÃæÓ°ÏìNo adverse effects were found. It was concluded that GM 356Ø43 was nutritionally equivalent to non-GM soybean with comparable genetic background

3¡¢Ïȷ湫˾¹¤³ÌʦDelaney et al. (2008)¡ªÏȷ湫˾DP-3Ø5423-1-- gm-fad2-1 gene fragment£¨ÂȻǡ¿¹ÐÔ»ùÒò£© and the gm-hra gene£¨ÂȻǡ¿¹ÐÔ»ùÒò£©--СÊóËÇιʵÑé
½áÂÛ£ºÎ´·¢ÏÖ¸ºÃæÓ°ÏìNo adverse effects on body weight/gain, food consumption, and mortality, clinical signs of toxicity or ophthalmological observations, neurobehavioral assessments, organ weights or clinical and anatomic pathology

4¡¢Mathesius et al. (2009)¡ªHRA ´ó¶¹¡ª×ªÂȻǡ¿¹ÐÔ»ùÒò¡ªÐ¡ÊóËÇι28Ìì
½áÂÛ£ºÎ´·¢ÏÖ¸ºÃæÓ°Ïì¡£No adverse effects

5¡¢Malatesta et al. (2008a)-- Soybean expressing CP4 EPSPS gene¡ª±í´ïepsps»ùÒòµÄ´ó¶¹£¨²Ý¸Ê좿¹ÐÔ»ùÒò£©--СÊóËÇιʵÑé
½áÂÛ£ºËÇιת»ùÒò´ó¶¹µÄСÊóijЩÓë¸Î´úл¹¦ÄÜ¡¢Ð²ÆÈÓ¦´ð¡¢Ca2+Ðźš¢ÏßÁ£ÌåÓйصĵ°°×Öʱí´ï¸Ä±ä¡£ËÇιת»ùÒò´ó¶¹µÄСÊó±íÏÖ³öÏßÁ£ÌåºÍϸ°ûºËµÄÐÞÊΣ¨£¿£©ËµÃ÷ÁË´úлËÙÂʵÄϽµ¡£Several proteins belonging  to hepatocyte metabolism, stress response, calcium signaling and mitochondria were differentially expressed in GM-fed mice indicating a more marked expression of senescence markers in comparison to controls. GM-fed mice showed mitochondrial and nuclear modifications indicative of reduced metabolic rate£¨Çë×¢ÒâÏÂÒ»Ìõ£©

6¡¢Cisterna et al. (2008)-- Soybean expressing CP4 EPSPS gene¡ª±í´ïepsps»ùÒòµÄ´ó¶¹£¨²Ý¸Ê좿¹ÐÔ»ùÒò£©--´ÆÐÔСÊóËÇιʵÑ飨Õû¸öÉúÃüÆÚ£¬>24¸öÔ£©
½áÂÛ£ºÅßÌ¥ÐÎ̬ѧÉϲ¢Îª³öÏÖ²»Í¬¡£ÏÔ΢¼°ÑÇÏÔ΢ϸ°ûµÄ¸Ä±ä¹é½áÓÚСÊó¶Ôת»ùÒò´ó¶¹µÄÉãÈ¡¡£No morphological differences in embryos of GM and non-Gm soybean-exposed groups. Microscopic and ultramicroscopic cellular changes attributed to GM soybean intake

7¡¢Malatesta et al. (2002a,b)--- SUPRO 500Eת»ùÒò´ó¶¹----£¿×ªµÄʲô»ùÒò£¿¡ªÐ¡ÊóËÇι30Ìì
½áÂÛ£º¶ÔÆäÓªÑøÐÔÄܲ¢ÎÞÓ°Ï죬´ÓÔçÆÚѸËٵĵÄPAP mRNA Ôö¼ÓºÍÒÈÏÙϸ°û¸Ä±äÍÆ¶Ï³öÒÈÏÙ¹¦Äܱ仯¡£No adverse effects in nutritional performance. Altered pancreas function evidenced by the early acute PAP mRNA increased levels and pancreas cellular changes

8¡¢Sakamoto et al. (2007)¡ª²Ý¸Êì¢ÄÍÐÔת»ùÒò´ó¶¹---СÊóËÇιʵÑ飨52ÖÜ£©
½áÂÛ£ºÎ´·¢ÏÖ¸ºÃæÓ°ÏìNo adverse effect in gross necropsy findings, hematological and serum biochemical parameters, organ weights and pathological findings

9¡¢Sakamoto et al. (2008)-- ²Ý¸Êì¢ÄÍÐÔת»ùÒò´ó¶¹---СÊóËÇιʵÑ飨104ÖÜ£©
½áÂÛ£ºÎ´·¢ÏÖ¸ºÃæÓ°ÏìNo adverse effect in gross necropsy findings, hematological and serum biochemical parameters, organ weights and pathological findings
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

wuwei_hello@163.com
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
»ØÌûÖö¥ ( ¹²ÓÐ2¸ö )

wuweibewin

½ð³æ (ÕýʽдÊÖ)

wuweibewin: »ØÌûÖö¥ 2012-06-05 19:55:47
¸ÐÐËȤµÄ»¹¿ÉÒÔÈ¥¿´
Mirid Bug Outbreaks in Multiple Crops Correlated with Wide-Scale Adoption of Bt Cotton in China
Yanhui Lu1,
Kongming Wu1,*,
Yuying Jiang2,
Bing Xia2,
Ping Li2,
Hongqiang Feng1,
Kris A. G. Wyckhuys1,† and
Yuyuan Guo1
wuwei_hello@163.com
4Â¥2012-06-05 19:54:14
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

wuweibewin

½ð³æ (ÕýʽдÊÖ)

wuweibewin: »ØÌûÖö¥ 2012-06-05 19:55:49
Impacts on Agroecosystems of Transgenic
Insect and Herbicide Resistance in Cotton
Lawrence C. Davis
ÕâÆª½éÉܸü¼Óϵͳ£¬µ«ÊÇÆª·ù¹ý´ó£¡²»Êʺϼòµ¥Á˽⣡
wuwei_hello@163.com
5Â¥2012-06-05 19:55:38
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
ÆÕͨ»ØÌû
¡ï
Сľ³æ: ɳ·¢+1£¬½ð±Ò+0.5, ¹§Ï²ÇÀ¸öɳ·¢£¬ÔÙ¸ø¸öºì°ü
2Â¥2012-06-05 19:50:57
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
¡ï
Сľ³æ: ½ð±Ò+0.2, ÇÀÁ˸öС°åµÊ£¬¸ø¸öºì°ü
3Â¥2012-06-05 19:51:05
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

bbk_2007

ľ³æ (ÖøÃûдÊÖ)

Æäʵ£¬ÎÒÊÇÕ¼×ùÀ´¿´¿ÚˮսµÄ¡£
6Â¥2012-06-05 21:12:05
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ wuweibewin µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] µ÷¼Á +4 13853210211 2026-03-24 4/200 2026-03-24 19:44 by ms629
[¿¼ÑÐ] ÊÕ08µ÷¼ÁÉú +6 komorebi69 2026-03-18 6/300 2026-03-24 19:09 by Íô£¡£¿£¡
[¿¼ÑÐ] »¯¹¤×¨Ë¶Çóµ÷¼Á +3 questionÍì·ç 2026-03-24 3/150 2026-03-24 18:48 by jhhcooi
[¿¼ÑÐ] ÕÐ08¿¼Êýѧ +7 laoshidan 2026-03-20 16/800 2026-03-24 17:52 by ÎÚÀ­¶ùɽÂö
[¿¼ÑÐ] 291Çóµ÷¼Á +3 HanBeiNingZC 2026-03-24 3/150 2026-03-24 16:34 by barlinike
[¿¼ÑÐ] 321Çóµ÷¼Á +4 Ymlll 2026-03-24 4/200 2026-03-24 14:44 by sprinining
[¿¼ÑÐ] 293Çóµ÷¼Á +6 ¼ÓÒ»Ò»¾Å 2026-03-24 6/300 2026-03-24 14:29 by JourneyLucky
[¿¼ÑÐ] 277·ÖÇóµ÷¼Á£¬¿çµ÷²ÄÁÏ +3 ¿¼Ñе÷¼Álxh 2026-03-24 3/150 2026-03-24 13:52 by JourneyLucky
[¿¼ÑÐ] Ò»Ö¾Ô¸»ª¶«Àí¹¤´óѧ081700£¬³õÊÔ·ÖÊý271 +5 kotoko_ik 2026-03-23 6/300 2026-03-24 10:29 by ѧÊõ°áשer
[¿¼ÑÐ] ²ÄÁÏרҵÇóµ÷¼Á +11 hanamiko 2026-03-18 11/550 2026-03-23 23:12 by peike
[¿¼ÑÐ] 291 Çóµ÷¼Á +4 »¯¹¤2026½ì±ÏÒµÉ 2026-03-21 5/250 2026-03-23 16:46 by »¯¹¤2026½ì±ÏÒµÉ
[¿¼ÑÐ] 280·ÖÇóµ÷¼Á Ò»Ö¾Ô¸085802 +4 PUMPT 2026-03-22 7/350 2026-03-22 22:13 by ÐÇ¿ÕÐÇÔÂ
[¿¼ÑÐ] 306Çóµ÷¼Á +5 À´ºÃÔËÀ´À´À´ 2026-03-22 5/250 2026-03-22 16:17 by BruceLiu320
[¿¼ÑÐ] Çóµ÷¼Á +3 13341 2026-03-20 3/150 2026-03-21 18:28 by ѧԱ8dgXkO
[¿¼ÑÐ] Ò»Ö¾Ô¸ÖØÇì´óѧ085700×ÊÔ´Óë»·¾³×Ü·Ö308Çóµ÷¼Á +7 īīĮ 2026-03-20 7/350 2026-03-21 16:36 by barlinike
[»ù½ðÉêÇë] ѧУÒѾ­Ìá½»µ½NSFC£¬»¹ÄÜÐÞ¸ÄÂ𣿠40+4 babangida 2026-03-19 9/450 2026-03-21 16:12 by babangida
[¿¼ÑÐ] 304Çóµ÷¼Á +6 ÂüÊâ2266 2026-03-18 6/300 2026-03-21 00:32 by JourneyLucky
[¿¼ÑÐ] 288Çóµ÷¼Á +16 ÓÚº£º£º£º£ 2026-03-19 16/800 2026-03-20 22:28 by JourneyLucky
[¿¼ÑÐ] 290Çóµ÷¼Á +7 ^O^Ø¿ 2026-03-19 7/350 2026-03-20 21:43 by JourneyLucky
[¿¼ÑÐ] Ò»Ö¾Ô¸¸£´ó288Óлú»¯Ñ§£¬Çóµ÷¼Á +3 Сľ³æ200408204 2026-03-18 3/150 2026-03-19 13:31 by houyaoxu
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û